1349972-68-4 Usage
General Description
3-(4-bromophenyl)oxetan-3-amine hydrochloride is a chemical compound with the molecular formula C9H11BrNO2.HCl. It is a yellow to beige solid that is soluble in water. 3-(4-broMophenyl)oxetan-3-aMine hydrochloride is commonly used as a building block in organic synthesis and pharmaceutical applications. It is also used in the research and development of new medicines and as a precursor for various drugs. The hydrochloride salt form of 3-(4-bromophenyl)oxetan-3-amine is important for enhancing the stability and solubility of the compound, making it suitable for use in pharmaceutical formulations. Additionally, this chemical is known for its potential as a therapeutic agent in the treatment of various diseases and conditions, including cancer and neurological disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 1349972-68-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,9,9,7 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1349972-68:
(9*1)+(8*3)+(7*4)+(6*9)+(5*9)+(4*7)+(3*2)+(2*6)+(1*8)=214
214 % 10 = 4
So 1349972-68-4 is a valid CAS Registry Number.
1349972-68-4Relevant articles and documents
Aryl alkylamine compound, preparation method thereof and application of aryl alkylamine compound in medicines
-
Paragraph 0172; 0184-0187, (2021/07/17)
The invention relates to an aryl alkylamine compound, a preparation method thereof and application of the aryl alkylamine compound in medicines. Particularly, the compound disclosed by the invention is suitable for being used as a calcium-sensitive recept
JAK kinase inhibitor and application
-
Paragraph 0217-0218; 0226-0228, (2018/09/08)
The present invention discloses a compound having the following general formula (I). The present invention also discloses a JAK kinase inhibitor comprising the compound and application of the compoundin preparation of a medicament for treating JAK-associated diseases. The JAK kinase inhibitor can inhibit the biological activities of JAK1, JAK2, JAK3 and TYK2 kinases involved in various kinds of signal transduction, can effectively treat various inflammatory diseases and various JAK-mediated signal transduction-driven diseases, and has a very broad application prospect.
